T2	Disorder 425 428	SSc
T3	Disorder 83 94	sarcoidosis
T6	GGPs 1201 1205	IL-8
T7	Disorder 556 559	SSc
T8	Subject 1134 1142	patients
T10	GGPs 1086 1094	cytokine
T11	Disorder 1224 1235	sarcoidosis
T16	GGPs 869 873	IL-6
T21	GGPs 1192 1196	IL-6
T24	GGPs 152 161	cytokines
T25	GGPs 483 487	IL-6
T27	GGPs 492 496	IL-8
T28	Disorder 435 460	interstitial lung disease
T30	GGPs 302 310	cytokine
T31	Disorder 535 546	sarcoidosis
T34	Disorder 206 227	pulmonary sarcoidosis
T38	Disorder 399 402	IPF
T39	Disorder 565 590	interstitial lung disease
T40	GGPs 19 23	IL-8
T41	Disorder 1273 1299	granulomatous lung disease
T42	GGPs 734 742	cytokine
T44	Artificial_process 1026 1041	steroid therapy
T45	Subject 69 77	patients
T46	GGPs 261 265	IL-8
T48	Disorder 345 366	pulmonary sarcoidosis
T52	Disorder 956 967	sarcoidosis
T54	Disorder 1049 1068	progressive disease
T55	GGPs 692 701	cytokines
T57	Disorder 368 397	idiopathic pulmonary fibrosis
T58	Subject 331 339	patients
T60	Disorder 637 648	sarcoidosis
T64	Subject 968 976	patients
T65	Disorder 548 551	IPF
E2	Artificial_process:T44 
N9	Reference T3 UMLS:C0036202	Sarcoidosis
N27	Reference T8 UMLS:C0030705	Patients
N33	Reference T10 UMLS:C0079189	cytokine
N36	Reference T11 UMLS:C0036202	Sarcoidosis
N77	Reference T24 UMLS:C0079189	cytokine
N90	Reference T28 UMLS:C0206062	Lung Diseases, Interstitial
N97	Reference T30 UMLS:C0079189	cytokine
N100	Reference T31 UMLS:C0036202	Sarcoidosis
N108	Reference T34 UMLS:C0036205	Sarcoidosis, Pulmonary
N125	Reference T38 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N127	Reference T39 UMLS:C0206062	Lung Diseases, Interstitial
N132	Reference T41 UMLS:C0746104	lung disease granulomatous
N136	Reference T42 UMLS:C0079189	cytokine
N140	Reference E2 UMLS:C0149783	Steroid therapy
N141	Reference T45 UMLS:C0030705	Patients
N150	Reference T48 UMLS:C0036205	Sarcoidosis, Pulmonary
N166	Reference T52 UMLS:C0036202	Sarcoidosis
N178	Reference T54 UMLS:C1335499	Progressive Disease
N185	Reference T55 UMLS:C0079189	cytokine
N189	Reference T57 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N192	Reference T58 UMLS:C0030705	Patients
N197	Reference T60 UMLS:C0036202	Sarcoidosis
N210	Reference T64 UMLS:C0030705	Patients
N212	Reference T65 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N3	Reference T2 UMLS:C0036421	Systemic Scleroderma
N4	Reference T7 UMLS:C0036421	Systemic Scleroderma
T20	Disorder 405 423	systemic screlosis
N5	Reference T20 UMLS:C0036421	Systemic Scleroderma
T19	Anatomical_entity 27 56	bronchoalveolar lavage fluids
N6	Reference T19 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T63	Cell 905 916	lymphocytes
N7	Reference T63 UMLS:C0024264	Lymphocyte
T62	Cell 929 939	CD3+ cells
N8	Reference T62 UMLS:C0882828	Cell positive for CD3 antigen
N10	Reference T40 UMLS:C0079633	Interleukin-8
N12	Reference T46 UMLS:C0079633	Interleukin-8
N13	Reference T27 UMLS:C0079633	Interleukin-8
N14	Reference T6 UMLS:C0079633	Interleukin-8
T66	GGPs 10 14	IL-6
N17	Reference T66 UMLS:C0021760	Interleukin-6
T67	GGPs 252 256	IL-6
N18	Reference T67 UMLS:C0021760	Interleukin-6
N22	Reference T21 UMLS:C0021760	Interleukin-6
N23	Reference T25 UMLS:C0021760	Interleukin-6
N24	Reference T16 UMLS:C0021760	Interleukin-6
T68	GGPs 779 786	albumin
N25	Reference T68 UMLS:C0001924	Albumins
T69	GGPs 807 815	cytokine
N26	Reference T69 UMLS:C0079189	cytokine
T70	Anatomical_entity 58 62	BALF
N28	Reference T70 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T71	Anatomical_entity 321 325	BALF
N30	Reference T71 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T72	Anatomical_entity 864 868	BALF
N31	Reference T72 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T73	Anatomical_entity 1105 1109	BALF
N32	Reference T73 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T74	Subject 995 1007	three groups
N34	Reference T74 UMLS:C1257890	Population Group
T75	Subject 465 481	control subjects
N35	Reference T75 UMLS:C0009932	Control Groups
T76	Subject 605 621	control subjects
N37	Reference T76 UMLS:C0009932	Control Groups
T5	Subject 623 631	Subjects
N15	Reference T5 UMLS:C0681850	Study Subject
T15	Subject 716 724	controls
N16	Reference T15 UMLS:C0009932	Control Groups
R1	Subject_Disorder Arg1:T45 Arg2:T3	
T53	Subject 331 339	patients
N19	Reference T53 UMLS:C0030705	Patients
T77	Subject 331 339	patients
N20	Reference T77 UMLS:C0030705	Patients
R2	Subject_Disorder Arg1:T77 Arg2:T48	
R3	Subject_Disorder Arg1:T53 Arg2:T57	
R4	Subject_Disorder Arg1:T58 Arg2:T20	
R5	Subject_Disorder Arg1:T5 Arg2:T60	
R6	Subject_Disorder Arg1:T64 Arg2:T52	
T78	Gene_expression 497 503	levels
T80	Gene_expression 677 683	levels
E4	Gene_expression:T80 Theme:T55
N40	Reference E4 UMLS:C1519614	Genetic Translation Process
T81	Gene_expression 1095 1101	levels
E5	Gene_expression:T81 Theme:T10
N43	Reference E5 UMLS:C1519614	Genetic Translation Process
T14	Positive_regulation 523 531	elevated
E6	Positive_regulation:T14 Theme:E18 disorder:T31
N42	Reference E6 UMLS:C1879547	Activation action
T23	Positive_regulation 667 676	increased
E7	Positive_regulation:T23 Theme:E4 disorder:T60
N44	Reference E7 UMLS:C1879547	Activation action
T59	Positive_regulation 1076 1085	increased
E8	Positive_regulation:T59 Theme:E5 atLoc:T73 Cue:T29
N45	Reference E8 UMLS:C1879547	Activation action
T79	Positive_regulation 1211 1220	increased
E9	Positive_regulation:T79 Theme:T6 disorder:T11 Cue:T43 Cue2:T61
N46	Reference E9 UMLS:C1879547	Activation action
T82	Biological_process 190 202	pathogenesis
E10	Biological_process:T82 Theme:T34
N47	Reference E10 UMLS:C0699748	Pathogenesis
T47	Positive_regulation 0 9	Increased
E11	Positive_regulation:T47 Theme:T40 atLoc:T19 disorder:T3
N48	Reference E11 UMLS:C1879547	Activation action
E12	Positive_regulation:T47 Theme:T66 atLoc:T19 disorder:T3
N49	Reference E12 UMLS:C1879547	Activation action
E13	Positive_regulation:T14 Theme:E16 disorder:T65
N50	Reference E13 UMLS:C1879547	Activation action
E14	Positive_regulation:T14 Theme:E3 disorder:T31
N51	Reference E14 UMLS:C1879547	Activation action
E16	Gene_expression:T78 Theme:T27
N53	Reference E16 UMLS:C1519614	Genetic Translation Process
E17	Gene_expression:T78 Theme:T27
N54	Reference E17 UMLS:C1519614	Genetic Translation Process
E18	Gene_expression:T78 Theme:T27
N55	Reference E18 UMLS:C1519614	Genetic Translation Process
E1	Gene_expression:T78 Theme:T25
N21	Reference E1 UMLS:C1519614	Genetic Translation Process
E3	Gene_expression:T78 Theme:T25
N39	Reference E3 UMLS:C1519614	Genetic Translation Process
E15	Gene_expression:T78 Theme:T25
N52	Reference E15 UMLS:C1519614	Genetic Translation Process
E19	Positive_regulation:T14 Theme:E1 disorder:T65
N57	Reference E19 UMLS:C1879547	Activation action
E20	Positive_regulation:T14 Theme:E15 disorder:T7
N59	Reference E20 UMLS:C1879547	Activation action
E21	Positive_regulation:T14 Theme:E17 disorder:T7
N60	Reference E21 UMLS:C1879547	Activation action
E22	Positive_regulation:T79 Theme:T21 disorder:T11 Cue:T43 Cue2:T61
N61	Reference E22 UMLS:C1879547	Activation action
T33	Correlation 881 891	correlated
E26	Correlation:T33 Theme:T16 Theme2:T63 Theme3:T62
N63	Reference E26 UMLS:C0332281	Associated with
T50	Correlation 1240 1250	correlated
E27	Correlation:T50 Theme:T21 Theme2:T6 Theme3:T41
N64	Reference E27 UMLS:C0332281	Associated with
R11	Subject_Disorder Arg1:T58 Arg2:T28	
T84	Subject 535 546	sarcoidosis
T85	Subject 548 551	IPF
T86	Subject 556 559	SSc
R12	Subject_Disorder Arg1:T86 Arg2:T39	
R13	Subject_Disorder Arg1:T85 Arg2:T39	
R14	Subject_Disorder Arg1:T84 Arg2:T31	
R15	Subject_Disorder Arg1:T85 Arg2:T65	
R16	Subject_Disorder Arg1:T86 Arg2:T7	
N56	Reference T84 UMLS:C0030705	Patients
N62	Reference T85 UMLS:C0030705	Patients
N65	Reference T86 UMLS:C0030705	Patients
R7	member_of Arg1:T74 Arg2:T64	
R17	part_of Arg1:T19 Arg2:T45	
T17	Correlation 243 248	roles
E24	Correlation:T17 Theme:T34 Theme2:T67 Theme3:T46
N66	Reference E24 UMLS:C0332281	Associated with
R18	part_of Arg1:T71 Arg2:T58	
R19	part_of Arg1:T71 Arg2:T53	
R20	part_of Arg1:T71 Arg2:T77	
T29	Speculation_cue 1069 1075	showed
T43	Speculation_cue 1150 1162	observations
T61	Speculation_cue 1163 1170	suggest
A1	Speculated E22
A2	Speculated E9
R21	member_of Arg1:T67 Arg2:T24	
R22	member_of Arg1:T46 Arg2:T24	
